Loading clinical trials...
Loading clinical trials...
A Phase II Trial of the HIV Protease Inhibitor Nelfinavir in Patients With Recurrent Symptomatic Adenoid Cystic Cancers of the Head and Neck
Conditions
Interventions
Nelfinavir
Locations
1
United States
The Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
Start Date
October 1, 2009
Primary Completion Date
May 1, 2015
Completion Date
November 1, 2017
Last Updated
October 9, 2019
NCT06998069
NCT06912087
NCT06303180
NCT05418842
NCT03914378
NCT06003231
Lead Sponsor
University of Iowa
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions